(Q35756909)

10 August 2017

1 reference

title

TRAIL and chemotherapeutic drugs in cancer therapy (English)

1 reference

10 August 2017

1 reference

Xiu-Xian Wu

1

1 reference

10 August 2017

Osamu Ogawa

series ordinal

2

1 reference

10 August 2017

Yoshiyuki Kakehi

series ordinal

3

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

published in

Vitamins and Hormones

1 reference

10 August 2017

volume

67

1 reference

10 August 2017

page(s)

365-383

1 reference

Death receptors: signaling and modulation

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Apoptosis control by death and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Structural and biochemical basis of apoptotic activation by Smac/DIABLO

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

The TRAIL to selective tumor death

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

The biochemistry of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Sensitization of human colon cancer cells to TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

REGULATION OF APO-2 LIGAND/TRAIL EXPRESSION IN NK CELLS—INVOLVEMENT IN NK CELL-MEDIATED CYTOTOXICITY

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

The potential of TRAIL for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Shared pathways: death receptors and cytotoxic drugs in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

APO2 ligand: a novel lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

1 reference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967019-1

7 January 2021

10.1016/S0083-6729(04)67019-1

Identifiers

DOI

1 reference

10 August 2017

1 reference